|
Re: Address your Shareholders Donald J. McCaffrey
|
2
|
Resverlogix Corp.
|
May 20, 2020 04:43PM
|
|
Re: AE/LFT concerns
|
7
|
Resverlogix Corp.
|
Nov 16, 2019 05:42PM
|
|
Re: Age, MoCA and CKD
|
3
|
Resverlogix Corp.
|
Nov 19, 2019 02:51PM
|
|
Re: Age, MoCA and CKD
|
2
|
Resverlogix Corp.
|
Nov 18, 2019 06:09PM
|
|
Re: Age, MoCA and CKD
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 12:36PM
|
|
Re: Age, MoCA and CKD
|
2
|
Resverlogix Corp.
|
Nov 19, 2019 08:42AM
|
|
Re: Age, MoCA and CKD
|
2
|
Resverlogix Corp.
|
Nov 19, 2019 09:01AM
|
|
Re: Age, MoCA and CKD
|
3
|
Resverlogix Corp.
|
Nov 19, 2019 09:19AM
|
|
Re: AGM
|
5
|
Resverlogix Corp.
|
Jun 06, 2023 08:03PM
|
|
Re: AHA 2020
|
3
|
Resverlogix Corp.
|
Sep 17, 2020 05:34PM
|
|
Re: AHA late breaking abstract
|
4
|
Resverlogix Corp.
|
Nov 10, 2019 04:04PM
|
|
Re: AHA late breaking abstract
|
3
|
Resverlogix Corp.
|
Nov 10, 2019 04:11PM
|
|
Re: AHA late breaking abstract
|
5
|
Resverlogix Corp.
|
Nov 10, 2019 04:15PM
|
|
Re: Albuminuria
|
5
|
Resverlogix Corp.
|
Dec 02, 2019 04:55PM
|
|
Re: All quiet on the western front
|
6
|
Resverlogix Corp.
|
Jan 04, 2020 03:45PM
|
|
Re: An ESC video from youtube that mentions Apabetalone, posted July 10 2019
|
6
|
Resverlogix Corp.
|
Sep 10, 2019 06:08PM
|
|
Re: Another article
|
2
|
Resverlogix Corp.
|
Nov 20, 2019 09:08PM
|
|
Re: Another Report of Exempt Distribution
|
6
|
Resverlogix Corp.
|
Mar 20, 2023 09:43AM
|
|
Re: Antiviral
|
2
|
Resverlogix Corp.
|
Apr 30, 2021 07:10PM
|
|
Re: Apabetalone
|
2
|
Resverlogix Corp.
|
Feb 02, 2020 07:01PM
|
